Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

KLOXXADO 8 MG NASAL SPRAY

Naloxone HCL
$59.7494per EA

Strength

8 mg/.1mL

Manufacturer

Hikma Specialty USA Inc.

NDC

59467067901

Classification

Brand

Dosage Form

SPRAY

Route

NASAL

Last Updated

4/22/2026

Active Ingredients

NALOXONE HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA212045

On Market Since

8/3/2021

Pharmacological Classes

Opioid Antagonist
Opioid Antagonists

Price History

1W

0.0%

1M

-0.1%

3M

-0.2%

6M

-0.3%

1Y

-0.5%

3Y

-0.1%

5Y

N/A

All

-0.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

SUBOXONE 2 MG-0.5 MG SL FILM
Brand
12496120203•Indivior Inc.
$4.7853
per EA
CONTRAVE ER 8-90 MG TABLET
Brand
51267089099•Nalpropion Pharmaceuticals LLC
$4.9810
per EA
ZUBSOLV 0.7-0.18 MG TABLET SL
Brand
54123090730•Orexo US, Inc.
$5.2599
per EA
ZUBSOLV 1.4-0.36 MG TABLET SL
Brand
54123091430•Orexo US, Inc.
$5.2767
per EA
SUBOXONE 4 MG-1 MG SL FILM
Brand
12496120403•Indivior Inc.
$8.5848
per EA
SUBOXONE 8 MG-2 MG SL FILM
Brand
12496120803•Indivior Inc.
$8.5983
per EA
ZUBSOLV 2.9-0.71 MG TABLET SL
Brand
54123092930•Orexo US, Inc.
$10.5396
per EA
ZUBSOLV 5.7-1.4 MG TABLET SL
Brand
54123095730•Orexo US, Inc.
$10.5559
per EA
MOVANTIK 12.5 MG TABLET
Brand
82625880101•Valinor Pharma, LLC
$14.6029
per EA
MOVANTIK 25 MG TABLET
Brand
57841130101•RedHill Biopharma Ltd
$14.6309
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy